ARCHIVES

Neratinib Graduates from I-SPY Phase II Adaptive Trial Regimen

This article is from The Cancer Letter archive.

Vol. 37 No. 4 | April 25, 2014

Download PDF Visit The Full Archive

Related Articles

Medenica Trial Begins In South Carolina

February 10, 1995

House Approves 1.9 Percent Increase For NIH.

July 20, 2007

Health Canada Suspends Avastin Approval; CMS Has Taken No Action After FDA Decision

December 2, 2011

Trombold Tells How Scripps Raises Money for Cancer Center, Gets Independent From “Whiny Administrator”

April 5, 1985

Long-term Hormonal Therapy Adds No Additional Benefits

September 27, 2013

NCI Research Project Grant Funding To Exceed $1 Billion In Fiscal 1997

March 14, 1997